Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.
about
Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosusIntrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagementAutoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodiesMelanocortin peptides: potential targets in systemic lupus erythematosusBiomarkers for CNS involvement in pediatric lupusLupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosusPredictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.Anti-endothelial antibodies and neuropsychiatric systemic lupus erythematosus.Anti-alpha-internexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis.Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus.Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus.Antiphospholipid syndrome and the brain in pediatric and adult patientsThe relationship between processing speed and working memory demand in systemic lupus erythematosus: evidence from a visual n-back taskAssociation between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus.Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice.Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.Ibuprofen fails to prevent brain pathology in a model of neuropsychiatric lupus.Neuroimaging evidence of white matter inflammation in newly diagnosed systemic lupus erythematosus.Autoantibody profiling on human proteome microarray for biomarker discovery in cerebrospinal fluid and sera of neuropsychiatric lupusAutoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus.Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials.Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohortHigh-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus.Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus.Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers.Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management.Systemic lupus erythematosus, the brain, and anti-NR2 antibodies.Interferons in the central nervous system: a few instruments play many tunes.Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus.Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based study.IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.Migraine in patients with systemic lupus erythematosus is associated with reduced cerebral grey matter volume but not with measures of glial activation or anti-NR2 or anti-P antibodies.Reduction of Cerebral and Corpus Callosum Volumes in Childhood-Onset Systemic Lupus Erythematosus: A Volumetric Magnetic Resonance Imaging Analysis.Intravenous immunoglobulins in refractory childhood-onset epilepsy: effects on seizure frequency, EEG activity, and cerebrospinal fluid cytokine profile.Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.The efficacy of brain (18)F-fluorodeoxyglucose positron emission tomography in neuropsychiatric lupus patients with normal brain magnetic resonance imaging findings.Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?Proclivity to self-injurious behavior in MRL-lpr mice: implications for autoimmunity-induced damage in the dopaminergic system.
P2860
Q24793525-50734D15-7871-484C-9943-11D8929991D9Q24798439-494EDA4F-6970-4AF0-A2E0-012055E2DB88Q24805595-D9268FB4-4B70-4370-A53E-54FF9A65E127Q26865343-BE49B77A-BC1F-45E9-A54E-0B83585F18D1Q28082493-47DE635C-C35A-4280-8409-4E85832E695FQ28268802-29169BC6-76F7-4019-86B4-B7F4F791DA60Q30956012-E9DDDEA0-E3B5-4DBB-9C09-6A68033100E7Q33251075-CE2C3F9A-4461-43F3-89B2-7BD64B2BAC2CQ33608727-CD586191-7AC1-4667-86DF-7A05CE363FAFQ33628713-4B480349-429B-44C5-BC56-305E50299A67Q33723529-7F26DA21-50A9-4DFC-A6A7-048657776DBEQ34307502-EDCA13D1-0172-478C-8445-0E84D246A801Q34681085-A10EC48D-499A-46A3-956A-169CF261DD7CQ34896821-2EC8D225-40E8-4784-B61E-2E17CE48AE8BQ35126682-F6EC1E1D-D65F-4525-BC8B-ECC2664DEB2AQ35126686-E7B9DC64-CF40-40B5-B364-789E124A436BQ35129267-6A63892D-E8BC-4D82-9221-AAEAB06185A1Q35199278-050DFD70-4775-4804-9673-8F638AE9243FQ35625134-FB8195D5-BCAD-4FA3-8573-A81978F3DD8AQ36332517-F4D92FBA-751D-4A1E-A67A-80335EF8CD53Q36896792-66D4296E-3DA6-4842-BAC7-F73660D3E47CQ36955326-E139B7FC-B4F0-4D4A-A72B-252446AD0096Q37137299-8C46BC5E-A463-4B32-8FAC-74A8F2084D98Q37161550-C962498E-31A0-400F-834D-BDB1D3FD8318Q37351240-B40E96B5-C3DD-46CF-B406-9467208BF441Q37556128-2D394D0F-E3BF-4BFC-A360-C4CF7658ACB6Q37922765-02121C70-E97F-4BE2-B121-06F72E96A503Q37930475-699F776A-B422-43A6-AB88-1307C69ECAD5Q38192651-6DAC31B8-86F6-458D-9BA0-CF0AEBCBDA50Q38237868-6070806A-E4D9-4E82-AFD9-875F87197EA3Q38247180-C514EC5A-6E40-444C-ACC7-B6C318C483ABQ40281523-9BFEFC58-09C0-4C07-A7FD-A9308FC1FC89Q40804722-2B970B9D-A851-47B2-BA14-4F53C9063377Q40826035-FEE21F5A-43AC-4E3E-8FD8-822C2C262A58Q40845375-2AB47C6F-40F3-4DC9-9CA8-E95BEE167A69Q42621543-199FCDC5-F8DD-426B-AB04-C571D8DC79DCQ46157365-343D4247-7DDC-4C8C-9F22-3F496A860759Q47196303-5FABED64-F730-442A-BC8B-488D1EB825C6Q48079168-707EECD1-E6EF-42CD-B606-84F7CB543C06Q48386139-ECF95F0F-4E31-4F2A-B8DA-4374B4B55488
P2860
Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Neuronal and astrocytic damage ...... al nervous system involvement.
@en
Neuronal and astrocytic damage ...... al nervous system involvement.
@nl
type
label
Neuronal and astrocytic damage ...... al nervous system involvement.
@en
Neuronal and astrocytic damage ...... al nervous system involvement.
@nl
prefLabel
Neuronal and astrocytic damage ...... al nervous system involvement.
@en
Neuronal and astrocytic damage ...... al nervous system involvement.
@nl
P2093
P2860
P356
P1476
Neuronal and astrocytic damage ...... al nervous system involvement.
@en
P2093
Andrej Tarkowski
Karin Nylen
Lars E Rosengren
P2860
P304
P356
10.1002/ART.11279
P577
2003-10-01T00:00:00Z